Gemtuzumab ozogamicin,cytarabine,daunorubicin,Vosaroxin,Decitabine
Pfizer
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'cardiff']
congress | #eha2023 steven knapper, highlights results from the ncri aml18 trial. the sequential addition of quizartinib to intensive chemotherapy was well tolerated but did not improve survival in older patients with aml. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm